This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB04381/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04381/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04381/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04381/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04381
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB04381 n7:DB04381
dcterms:title
Crotonaldehyde
adms:identifier
n10:CRD n11:447466 n12:DB04381 n13:46506682
n3:synthesisReference
Luciano Re, Giancarlo Eletti Bianchi, Felice Centini, "Method for the preparation of 4-chloro-2-methyl-crotonaldehyde." U.S. Patent US4054608, issued August, 1966.
n3:IUPAC-Name
n6:271B54EA-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B54F0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B54EF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B54EC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B54ED-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B54EE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B54E8-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B54E9-363D-11E5-9242-09173F13E4C5 n6:271B54E6-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B54E7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B54F6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B54F7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B54F1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B54F2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B54F4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B54F3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B54F5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B54FB-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B54FD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B54FE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B54FA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B54F9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B54FC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B54EB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B54F8-363D-11E5-9242-09173F13E4C5